| Literature DB >> 31547149 |
Jennifer R Bailey1, Jonathan Breton2, Gordana Panic3, Tristan A Cogan4, Michael Bailey5, Jonathan R Swann6, Michael R F Lee7,8.
Abstract
Entities:
Keywords: cell cycle arrest; metabolic profiling; mycotoxicosis; protein synthesis
Year: 2019 PMID: 31547149 PMCID: PMC6832441 DOI: 10.3390/toxins11100554
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Cytotoxicity and metabolic activity of Madin–Darby bovine kidney (MDBK) cells following exposure to deoxynivalenol (DON), zearalenone (ZEN), fumonisin B1 (FB1), and patulin (PA). Percent cell death in MDBK populations treated with DON (A), ZEN (B), FB1 (C), or PA (D); cell death was significantly increased when compared to control populations when cells were exposed to DON, ZEN, and PA. Metabolic activity was significantly reduced following exposure to DON (E), FB1 (G), and PA (H) but not ZEN (F). Data are shown from four replicate experiments and are presented as mean ± standard error of the mean (SEM). * p < 0.05, ** p < 0.01, and *** p < 0.001. O.D. = optical density.
Figure 2Principal-components analysis (PCA) models comparing the intracellular metabolic profiles of all cells from the study measured by 1H NMR spectroscopy. (A) Scores plot from the PCA model comparing the intracellular metabolic profiles from all cells (PC1 vs. PC2; R2 = 18.3%). Scores plots from pairwise PCA models comparing (B) control and DMSO-treated cells (PC1 vs. PC2; R2 = 35.1%), and DMSO-treated cells with those treated with (C) 0.5 µg/mL fumonisin B1/DMSO (PC1 vs. PC2; R2 = 21.6%) (FB1), (D) 20 µg/mL zearalenone (ZEN)/DMSO (PC1 vs. PC2; R2 = 20.2%), and (E) 0.1 µg/mL patulin (PA)/DMSO (PC1 vs. PC2; R2 = 20%).
Figure 3Biochemical perturbations induced by DON in MDBK cells. (A) PCA model constructed on the 1H NMR profiles of cell extracts obtained from MDBK cells treated with DMSO and DON/DMSO. Scores plot (PC1 vs. PC2; R2 = 26.3%) showing clear metabolic variation between the cells following exposure to DON. (B) Coefficients plot extracted from the partial least squares-discriminant analysis (PLS-DA) model comparing the intracellular metabolic profiles of DMSO and DON/DMSO-treated cells (Q2Y = 0.88; p = 0.001). 2OG = 2-oxoglutarate; 3-HB = 3-hydroxybutyrate; myo-inos = myo-inositol; UDP-NAG = UDP-N-acetylglucosamine; U1 = Unknown metabolite.
Figure 4Cells treated with DON showed significantly reduced levels of protein synthesis compared to controls. De novo protein synthesis was detected in populations of MDBK cells exposed to DON/DMSO or DMSO (control) by production of a green signal, visible by immunohistology. The intensity of this signal in cytoplasm (A) and nuclei (B) was quantified, demonstrating that treatment with DON/DMSO reduced this signal; a representative analysis from single images is shown. Exposure to DON/DMSO significantly reduced de novo protein synthesis when compared to control populations of cells (C); data are shown from five replicate experiments and are expressed as mean + standard deviation (SD). Representative 20× magnified images from cells treated with DMSO (D) and DON/DMSO (E) are shown; green represents de novo protein synthesis and blue is a DAPI nuclear stain. **** indicates p < 0.0001.
Figure 5Cells treated with DON show reduced levels of proliferation, even at quite low concentrations of DON. Proliferation of MDBK cells was significantly reduced following exposure to concentrations of DON greater or equal to 0.16 µg/mL when compared to control cells (A). DON-treated cells accumulated in the G1 phase of the cell cycle (B) and failed to progress to S phase (C) and the subsequent G2 phase (D). Data are shown from six replicate experiments and are represented as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Figure 6Model of DON toxicity to bovine renal epithelial cells. (A) DON inhibits protein translation, which triggers a ribotoxic stress response involving activation of the mitogen-activated protein kinases (MAPK) pathways, possibly the extracellular signal-regulated kinases 1 and / MAPK (ERK1/2 MAPK) cascade which upregulates p21 and arrests cell cycle at S phase. (B) DON peroxidates both mitochondrial and cell membranes. The damage to mitochondrial membrane integrity induces the hypoxia-induced- factor (HIF) pathway described in renal cells, which would switch oxidative respiration to anaerobic glycolysis and promote fatty acid production. Simultaneously, damage to the cell membrane would induce osmoregulatory responses which would sequester free amino acids (leucine, isoleucine, valine, glutamine, glutamate, lysine, and alanine) while excreting osmolytes beta-alanine, taurine, and myo-inositol. Green metabolites were increased with DON exposure and orange metabolite were depleted with DON. Image components from Smart Servier Medical Art (Creative Commons license CC BY 4.0).